NANOFLUIDETEC

Detection of SARS-CoV-2 using PCR, nanotechnology and microfluidics

NANOFLUIDETEC is an initiative to develop a method for rapid, automated detection of SARS-CoV-2 based on PCR, nanotechnology and microfluidics (IN852D 2021/5), driven by a consortium consisting of AMSlab (project leader), AMSbiopharma, BFlow and the Lugo campus of the University of Santiago de Compostela, through the Single Molecule Fluorescence Research Unit.

The project’s overall objective is to develop a point-of-care system for the detection of SARS-CoV-2 based on molecular techniques that integrate nanotechnology and microfluidics with automation and potential connectivity for communication.

Through this project, NANOFLUIDETEC will incorporate Essential Enabling Technologies (EETs) into the research and development of new products with high added value to explore new markets based on the integration of science and technology, especially in the areas of genetics, nanotechnology, microelectronics, photonics, biotechnology, advanced manufacturing and processing, and their application and operability through information and communication technologies (ICT).

The project is subsidised by the Galician Innovation Agency (GAIN), funded by ERDF and has the support of the Xunta de Galicia (Regional Government of Galicia) through the second vice-presidency and the Regional Ministry of Economy, Enterprise and Innovation. The initiative is funded through the CONECTA COVID 2021 programme within the REACT-EU framework of the ERDF Galicia 2014-2020operational programme as part of the European Union’s response to the COVID-19 pandemic.

Total budget: €258,751.04.